| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |